Literature DB >> 17761816

Ethics, justification and the prevention of spina bifida.

Wendy Jane Gagen1, Jeffrey P Bishop.   

Abstract

During the 1970s, prenatal screening technologies were in their infancy, but were being swiftly harnessed to uncover and prevent spina bifida. The historical rise of this screening process and prevention programme is analysed in this paper, and the role of ethical debates in key studies, editorials and letters reported in the Lancet, and other related texts and governmental documents between 1972 and 1983, is considered. The silence that surrounded rigorous ethical debate served to highlight where discussion lay-namely, within the justifications offered for the prevention of spina bifida, and the efficacy and benefits of screening. In other words, the ethical justification for screening and prevention of spina bifida, when the authors are not explicitly interested in ethics, is considered. These justifications held certain notions of disability as costly to society, with an imperative to screen and prevent spina bifida for the good of the society.

Mesh:

Year:  2007        PMID: 17761816      PMCID: PMC2598205          DOI: 10.1136/jme.2006.018697

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  21 in total

1.  Review article: the resistible rise of medical ethics.

Authors:  R Cooter
Journal:  Soc Hist Med       Date:  1995-08       Impact factor: 0.973

2.  Letter: Towards the prevention of spina bifida.

Authors:  C B Goodhart
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

3.  Fetal malformations and abnormalities.

Authors:  K M Laurence
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

4.  Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida.

Authors:  D J Brock; R G Sutcliffe
Journal:  Lancet       Date:  1972-07-29       Impact factor: 79.321

5.  Ethical and social aspects of treatment of spina bifida.

Authors:  R B Zachary
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

6.  Ultrasound in the diagnosis of spina bifida.

Authors:  S Campbell; J Pryse-Davies; T M Coltart; M J Seller; J D Singer
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

7.  Our lives and hard times.

Authors:  T W Meade
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

8.  Letter: Screening for neural-tube defects.

Authors:  F Carter; S Hagard
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

9.  Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect.

Authors:  P C Leighton; M J Kitau; T Chard; Y B Gordon; A E Leek
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

10.  Early results of selective treatment of spina bifida cystica.

Authors:  J Lorber
Journal:  Br Med J       Date:  1973-10-27
View more
  1 in total

1.  Making birth defects 'preventable': pre-conceptional vitamin supplements and the politics of risk reduction.

Authors:  Salim Al-Gailani
Journal:  Stud Hist Philos Biol Biomed Sci       Date:  2013-11-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.